Article
EGFR mutation in kidney carcinoma confers sensitivity to gefitinib treatment: a case report.
Urologic oncology - 1 Jan 2000
Iyevleva Aglaya G, Novik Alexey V, Moiseyenko Vladimir M, Imyanitov Evgeny N
Abstract excerpt
Mutations of the epidermal growth factor receptor (EGFR) gene are known to be associated with the pronounced tumor response to EGFR tyrosine kinase inhibitors (TKI). Unfortunately, these TKI-sensitizing alterations have been detected almost exclusively in lung adenocarcinomas; indeed, their occur...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.